World neurosurgery · 2026
Maximal Safe Resection and Targeted Intracavitary Therapy in Cladophialophora bantiana Brain Abscess: Illustration and Systematic Review.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Taman Mazen, Teshome Abigail A, Porto Carl, Dailey Jennifer, Tung Glenn, Burns Rebecca, Punsoni Michael, Farmakiotis Dimitrios, Malik Athar N
Аннотация
INTRODUCTION: Cladophialophora bantiana (C. bantiana) brain abscess is a rare dematiaceous mold infection often refractory to conventional treatment. Aspiration is commonly used for diagnosis and decompression, while resection may provide greater source control when anatomically feasible; however, comparative evidence remains limited and confounded.
METHODS: We report an illustrative surgically managed case and performed a PRISMA-guided systematic review with patient-level analysis to characterize management strategies and outcomes.
RESULTS: A 60-year-old immunocompromised male with symptomatic C. bantiana brain abscess underwent repeated resections, Ommaya-enabled intracavitary amphotericin B, systemic antifungals, and fosmanogepix, returning to neurologic baseline through two-year follow-up. Among 103 cases, 42 patients survived at last reported follow-up. Five patients had no abscess-directed operation, none of whom survived; 29 underwent aspiration-only, of whom 10 survived; and 69 underwent resection, of whom 32 survived. Among abscess-resected patients, 11/31 with unspecified extent of resection, 7/18 with subtotal resection, and 14/20 with gross total resection survived. Fourteen patients underwent ≥2 resections, of whom 9 survived; 3 underwent ≥3 resections, all of whom survived. Eight patients received an Ommaya reservoir; of whom 3 survived; all 3 survivors had also undergone gross total resection.
CONCLUSIONS: These findings support source-control centered multidisciplinary management of C. bantiana brain abscess, with highest survival observed in selected patients who underwent reported GTR. Repeat resection and Ommaya-enabled intracavitary amphotericin B may be considered in selected complex cases. Standardized reporting of operative extent, reoperation timing, and antifungal protocols will help refine care.
METHODS: We report an illustrative surgically managed case and performed a PRISMA-guided systematic review with patient-level analysis to characterize management strategies and outcomes.
RESULTS: A 60-year-old immunocompromised male with symptomatic C. bantiana brain abscess underwent repeated resections, Ommaya-enabled intracavitary amphotericin B, systemic antifungals, and fosmanogepix, returning to neurologic baseline through two-year follow-up. Among 103 cases, 42 patients survived at last reported follow-up. Five patients had no abscess-directed operation, none of whom survived; 29 underwent aspiration-only, of whom 10 survived; and 69 underwent resection, of whom 32 survived. Among abscess-resected patients, 11/31 with unspecified extent of resection, 7/18 with subtotal resection, and 14/20 with gross total resection survived. Fourteen patients underwent ≥2 resections, of whom 9 survived; 3 underwent ≥3 resections, all of whom survived. Eight patients received an Ommaya reservoir; of whom 3 survived; all 3 survivors had also undergone gross total resection.
CONCLUSIONS: These findings support source-control centered multidisciplinary management of C. bantiana brain abscess, with highest survival observed in selected patients who underwent reported GTR. Repeat resection and Ommaya-enabled intracavitary amphotericin B may be considered in selected complex cases. Standardized reporting of operative extent, reoperation timing, and antifungal protocols will help refine care.